ArticleBritish journal of cancer2018

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.

Jun Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.